Anzeige
Mehr »
Login
Montag, 13.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Die 1 Billionen Dollar Mine: Power Nickels Weg zur globalen Dominanz!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
436 Leser
Artikel bewerten:
(2)

Cinedigm Corp.: Cinedigm Acquires The Frightening New Feature THE STAIRS Releasing This Summer

Finanznachrichten News

LOS ANGELES, CA / ACCESSWIRE / April 7, 2021 / After a great reception on the horror festival circuit, Cinedigm Corp (NASDAQ:CIDM) announced today that it has acquired all North American rights to the horror film THE STAIRS. The film is anchored by a cast of acting veterans, led by John Schneider (The Dukes of Hazzard) and Academy Award® nominated Kathleen Quinlan (Apollo 13); it also features Adam Korson (Imposters), Brent Bailey (Agents of S.H.I.E.L.D.) and Stacey Oristano (Friday Night Lights). This chilling new film will be available on demand and digital this Summer.

THE STAIRS signals a further commitment by Cinedigm to invest in this rapidly growing genre. Last month, the Company announced the acquisition of the subscription-based Screambox, a video-on-demand service which is one of the country's leading streaming platforms for Horror Movies and TV Series. With a strong catalog of Horror titles, Cinedigm is now one of the premiere digital destinations for the genre.

What started as a week's long adventure with friends, quickly turns into a terrifying fight for survival in THE STAIRS. In 1997, a young boy is out hunting with his grandfather (Schneider), when he stumbles upon a mysterious staircase deep in the forest. The subsequent disappearance leaves locals baffled as to the fate of the wayward pair. Twenty years later, a group of hikers set off on an ambitious trail, deep into the same stretch of wilderness where they stumble upon the same set of ominous stairs. Descending deep below the earth, they find themselves coming face to face with the thing that nightmares are made of.

Directed by Peter "Drago" Tiemann, THE STAIRS blends the sweeping natural beauty of the Pacific Northwest with the stomach-churning gore of Hollywood, in this modern-day monster movie. Written by Tiemann and Jason L Lowe, both men took on additional roles for the film; Tiemann Producing and Lowe working as an Executive Producer. Also Produced by Amanda Rae Jones, with additional Executive Producers Andrew Nevils, Christopher Hill & Amy Bovenkamp, John Kritsonis, Karl Lindor, Thomas Lowe, Wesley Barker and Scott Riefler.

"I am thrilled to finally be able to share THE STAIRS with everyone," said the first-time director, Tiemann. "I fell in love with horror as a young boy, and soon found a way to turn my passion into a career. For this story, I wanted to give the cast, crew and audience a visceral experience, and I hope you enjoy watching it as much as we enjoyed making it."

"THE STAIRS truly delivers for horror fans looking for a movie with real scares, suspense and a terrifying conclusion," said Melody Fowler, Vice-President of Acquisitions for Cinedigm. "Along with its satisfying story and well-developed characters, the film features superb stunts and inventive creature design and effects. All of these elements together elevate THE STAIRS, and the film's strong festival reception with genre fans further confirms that it is a must-see."

This film is currently on the festival circuit, and as of this press release, has been the Official Selection in 9 Film Festivals with 14 nominations and 12 wins including Best Picture (Audience Award) at Nevermore Film Festival. In addition, THE STAIRS was nominated for 6 awards at the HorrorHound Film Festival - Best Directing, Best Writing, Best Cinematography, Best Sound Design, Best Special Effects Feature and Best Feature Film. The film just won Best Feature at Haunted House Fear Fest.

The deal was negotiated by Melody Fowler, Vice-President, Acquisitions, on behalf of Cinedigm, with Amanda Rae Jones and Peter 'Drago' Tiemann, on behalf of Wandering Dragon Productions.

ABOUT CINEDIGM

For more than twenty years, Cinedigm (NASDAQ:CIDM) has led the digital transformation of the entertainment industry. Today, Cinedigm entertains hundreds of millions of consumers around the globe by providing premium content, streaming channels and technology services to the world's largest media, technology and retail companies. For more information, visit http://www.cinedigm.com/.

For additional information, please contact:

Jill Calcaterra
E: jcalcaterra@cinedigm.com

Kim Staruk
E: kstaruk@cinedigm.com

SOURCE: Cinedigm Corp.



View source version on accesswire.com:
https://www.accesswire.com/638426/Cinedigm-Acquires-The-Frightening-New-Feature-THE-STAIRS-Releasing-This-Summer

© 2021 ACCESSWIRE
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.